buyout·deskPrivate equity, daily
Mon, Jul 27, 2026
Daily briefMonday, July 27, 2026
20 deals tracked · Updated 12:29 PM PDT·Full deal sheet
Platform·Healthcare/Medical Devices·July 27, 2026

RS2 Healthcare Partners backs KMM Group

The Hatboro, Pennsylvania-based contract manufacturer produces tight-tolerance components for medical device companies; RS2 has installed J. Mark King as CEO while co-founders remain in technology leadership roles.

Takeaways

  • KMM Group is a precision contract manufacturer specializing in complex, tight-tolerance components for the medical device industry.
  • RS2 Healthcare Partners is acquiring KMM Group.
  • The target serves medical device across Hatboro, Pennsylvania.
BuyerRS2 Healthcare Partners
TargetKMM Group
SponsorRS2 Healthcare Partners
TypePlatform
GeographyHatboro, Pennsylvania
IndustryHealthcare
Sub-sectorMedical Devices

RS2 Healthcare Partners has formed a new platform around KMM Group, a Hatboro, Pennsylvania-based precision contract manufacturer that specializes in complex, tight-tolerance components for the medical device industry.

Co-founders John Shegda and Eric Wilhelm will remain with the business as CTO and EVP of Business Transformation & Organizational Capability, while RS2 installed J.

Mark King, the former CEO of Tegra Medical, as president and CEO.

"KMM is an exceptional company, with an excellent reputation in the marketplace, highly specialized capabilities, a blue chip customer base, and an extremely dedicated group of employees," said Craig Stern, Co-Managing Partner at RS2 Healthcare Partners.

RS2, based in Boston, has raised $1.6 billion in total capital commitments since its founding in 1989 and focuses on founder-owned healthcare companies.